Peter H. Griffith's most recent trade in AMGEN Inc. was a trade of 3,305 Common Stock done at an average price of $313.7 . Disclosure was reported to the exchange on March 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.71 per share. | 17 Mar 2025 | 3,305 | 40,334 (0%) | 0% | 313.7 | 1,036,812 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 7,277 | 43,502 (0%) | 0% | 0 | Common Stock | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 20,767 | 20,767 | - | - | Nqso (Right to Buy) | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,196 | 35,973 (0%) | 0% | 0 | Common Stock | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.29 per share. | 05 May 2024 | 648 | 32,777 (0%) | 0% | 311.3 | 201,716 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.37 per share. | 02 May 2024 | 682 | 33,425 (0%) | 0% | 277.4 | 189,166 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.38 per share. | 30 Apr 2024 | 603 | 34,107 (0%) | 0% | 276.4 | 166,657 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 268.87 per share. | 18 Mar 2024 | 5,168 | 34,710 (0%) | 0% | 268.9 | 1,389,520 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 10,338 | 39,250 (0%) | 0% | 0 | Common Stock | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.89 per share. | 05 May 2023 | 608 | 31,990 (0%) | 0% | 231.9 | 140,989 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 32,250 | 32,250 | - | - | Nqso (Right to Buy) | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 3,814 | 32,598 (0%) | 0% | 0 | Common Stock | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.74 per share. | 30 Apr 2023 | 583 | 28,784 (0%) | 0% | 239.7 | 139,768 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 234.57 per share. | 17 Mar 2023 | 3,403 | 29,367 (0%) | 0% | 234.6 | 798,242 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 7,753 | 32,541 (0%) | 0% | 0 | Common Stock | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.35 per share. | 01 Nov 2022 | 3,030 | 24,675 (0%) | 0% | 270.4 | 819,161 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.10 per share. | 05 May 2022 | 589 | 27,340 (0%) | 0% | 236.1 | 139,063 | Common Stock |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 May 2022 | 31,817 | 31,817 | - | - | Nqso (Right to Buy) | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 3,897 | 27,929 (0%) | 0% | 0 | Common Stock | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 28,985 | 28,985 | - | - | Nqso (Right to Buy) | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 3,338 | 25,960 (0%) | 0% | 0 | Common Stock | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 28,341 | 28,341 | - | - | Nqso (Right to Buy) | |
AMGEN Inc. | Peter H. Griffith | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 3,384 | 21,990 (0%) | 0% | 0 | Common Stock |